Diagnostics
Colorectal Polyp Size Often Over-Estimated, Study Shows
Endoscopists greatly overestimate the true size of the colorectal polyps they resect, according to a large study presented at Digestive Disease Week 2022.
MAY 24, 2022
Using AI to Predict VTE Risk in Cancer Pts
Artificial intelligence and machine learning could improve the ability to predict VTE in cancer patients over the current gold-standard approaches.
MAY 17, 2022
Circulating Extracellular Vesicle Biomarkers May Detect Early-Stage Cancers
A “liquid biopsy” that identifies tumor protein biomarkers found in circulating extracellular vesicles (EV) could help detect early-stage pancreatic, ovarian and bladder cancers, results from a new study show.
APRIL 19, 2022
Unraveling the Uncertainty of Endoscopic Surveillance of Colorectal Lesions
Surveillance colonoscopy aims to detect and resect metachronous premalignant lesions that occur after polypectomy or cancer resection.
APRIL 13, 2022
In Meta-Analysis, Multitarget Liquid Biopsy Superior for Early HCC Detection
The results of a recent meta-analysis indicate that multitarget hepatocellular carcinoma liquid biopsy is more sensitive than either ultrasound or alpha-fetoprotein alone for detecting HCC in patients with cirrhosis.
JANUARY 31, 2022
IL-6 Is Biomarker for Distant Recurrence of Stage II/III Breast Cancer
Interleukin-6 appears to be a biomarker for distant recurrence in patients treated for stage II to III, HER2-negative early breast cancer, according to a case-control study of patients in the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E5103 trial.
OCTOBER 27, 2021
Genotyping Not Yet Appreciated As ChemoRx Tool
Pharmacogenetic testing for DPYD and UGT1A1 gene variants could cost-effectively prevent severe chemotherapy-related toxicity, but there are barriers to its uptake, two research teams reported at the 2021 Gastrointestinal Cancers Symposium.
JULY 9, 2021
ESMO: When to Order Next-Gen Cancer Sequencing
New recommendations for using next-generation sequencing in the setting of metastastic cancer have been published by the European Society for Medical Oncology (ESMO).
DECEMBER 16, 2020
Cell-Free DNA Blood Tests Detect Various Cancers
Noninvasive cell-free DNA (cfDNA) blood tests are showing the potential to detect cancers years before conventional diagnostic methods.
AUGUST 5, 2020
FDA Warns of False Positives With BD SARS-CoV-2 Reagents
In one study, the manufacturer found approximately 3% of results were false-positive results.
JULY 17, 2020
False Negatives Found If COVID-19 Testing Done Too Soon
Johns Hopkins researchers found that testing for SARS-CoV-2 too early in the course of infection is likely to result in false-negative test results, even though the patient may eventually test positive for the virus.
JUNE 19, 2020
Liquid Biopsy Predicts Outcomes in Stage III Melanoma
A commercially available liquid biopsy test can predict survival outcomes up to 54 months after initial presentation in patients with stage III melanoma, according to a report in Clinical Cancer Research.
JUNE 4, 2020
